• Publications
  • Influence
A randomized double‐blind study of low‐molecular‐weight heparin (parnaparin) for superficial vein thrombosis: STEFLUX (Superficial ThromboEmbolism and Fluxum)
Summary.  Background:  Optimal doses and duration of low‐molecular‐weight heparin (LMWH) for the treatment of superficial vein thrombosis (SVT) are still uncertain.
Risk factors for recurrent events in subjects with superficial vein thrombosis in the randomized clinical trial SteFlux (Superficial Thromboembolism Fluxum).
BACKGROUND/AIMS To evaluate risk factors for recurrent events in patients enrolled in the SteFlux (Superficial Thromboembolism Fluxum) clinical trial which compared different doses and duration ofExpand
Proximal and isolated distal deep vein thrombosis and Wells score accuracy in hospitalized patients
Deep vein thrombosis (DVT) is an important cause of morbidity and mortality in hospitalized patients. The Wells score for DVT pretest probability (PTP) was validated in outpatients, but its utilityExpand
Short- and Long-Term Stroke Risk after Urgent Management of Transient Ischaemic Attack: The Bologna TIA Clinical Pathway
Background: Rapid management can reduce the short stroke risk after transient ischaemic attack (TIA), but the long-term effect is still little known. We evaluated 3-year vascular outcomes in patientsExpand
Prospective observational cohort study of early recurrent TIA
Objectives To evaluate the frequency, clinical and etiologic features, and short- and long-term outcomes of early recurrent TIA. Methods This prospective observational cohort study enrolled allExpand
Vascular endothelial dysfunction in primary open angle glaucoma
Purpose Glaucomatous optic neuropathy (GON) is related not only to elevated intraocular pressure (IOP) but also to an insufficient ocular blood supply related to a vascular dysregulation. WeExpand